New Pfizer Breakthrough Miraculously Extends Lifespan Of Near-Death Patents

Top Headlines

Recent News

Goodwill Executives Arrested After Years Of Skimming Donated Goods Off Top

ROCKVILLE, MD—In what authorities are calling one of the most wide-reaching and deplorable cases of embezzlement in recent history, seven executives at Goodwill Industries International were arrested Thursday for allegedly skimming used clothing, old furniture, small appliances, and thousands of other donated items from the charitable group.

Meteorologists Say Upcoming Hurricane Season To Be Permanent

SILVER SPRING, MD—Warning residents to prepare for extreme winds, heavy rainfall, and flooding starting in the near future and continuing indefinitely, meteorologists at the National Weather Service announced Friday that the upcoming hurricane season would be permanent.
End Of Section
  • More News
TV Listings
Just Like Everything Else!: Fox 8 p.m. EDT/7 p.m. ABC Pete's wife is still on him about building that darn shed, these kids are going to be the death of Sheila and Dave, and the hot next-door neighbor is up in EVERYBODY'S business! Sunday nights on ABC couldn't be any more familiar!

Special Coverage

Protection

  • Guards Gun Down Four Angels Escaping From Heaven

    THE HEAVENS—Killing four and critically wounding several others, armed guards dispatched from the Right Hand of God reportedly opened fire early Monday morning on a group of angels attempting to escape from heaven. One of the Eternal Kingdom’s...

Good Times

New Pfizer Breakthrough Miraculously Extends Lifespan Of Near-Death Patents

NEW YORK—Hailing it as a groundbreaking discovery with far-ranging benefits, pharmaceutical company Pfizer announced a new breakthrough Friday that vastly extends the lifespan of near-death patents. “Ensuring that every one of these patents lives a long and fruitful life is our highest priority, and we’re committed to doing everything in our power to make sure they survive,” said Pfizer spokeswoman Ellen Hilty, noting that the drug manufacturer with more than $50 billion in annual revenues had assembled elite teams of experts and dedicated years of intense work to finding a way to prolong the lives of dying patents. “At Pfizer, patents always come first. Our primary goal is, and always will be, keeping them alive and healthy for as long as possible. And that’s why we couldn’t be happier to announce this wonderful development.” Hilty added that nothing causes Pfizer officials more distress than seeing a once robust patent expire at a young age, a “terrible tragedy” that allows dozens of generic manufacturers to copy it and offer pharmaceuticals to customers far more cheaply.